Colgate-Palmolive (NYSE:CL) Shares Acquired by Syon Capital LLC

Syon Capital LLC raised its holdings in shares of Colgate-Palmolive (NYSE:CL) by 89.9% in the 4th quarter, HoldingsChannel reports. The fund owned 7,394 shares of the company’s stock after buying an additional 3,501 shares during the quarter. Syon Capital LLC’s holdings in Colgate-Palmolive were worth $589,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in CL. OFI Invest Asset Management purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $25,000. Avion Wealth lifted its holdings in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $34,000. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in shares of Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares during the last quarter. Finally, West Branch Capital LLC lifted its holdings in shares of Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after purchasing an additional 132 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a report on Thursday, January 18th. UBS Group increased their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Morgan Stanley increased their price objective on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. Citigroup increased their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. Finally, Stifel Nicolaus increased their price objective on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $89.50.

Insiders Place Their Bets

In other news, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 232,371 shares of company stock valued at $19,505,099. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock traded up $1.72 during midday trading on Friday, hitting $91.01. 7,417,211 shares of the stock were exchanged, compared to its average volume of 4,608,002. The stock’s 50-day moving average price is $87.51 and its 200-day moving average price is $81.30. The stock has a market cap of $74.81 billion, a price-to-earnings ratio of 32.59, a PEG ratio of 3.34 and a beta of 0.42. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $92.12. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. The company had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. Colgate-Palmolive’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.73 earnings per share. Research analysts predict that Colgate-Palmolive will post 3.5 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a yield of 2.20%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 71.94%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.